| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK-2118436 mesylate |
|---|
| Description | GSK2118436 is a selective BRAF V600E inhibitor. GSK2118436 binds to Raf family kinases and inhibits their activity. It is highly selective against B-Raf V600E with IC50 of 0.8 nM, compared to wild type B-Raf and c-Raf with IC50s of 3.2 nM and 5.0 nM, respectively. MW: 615.67. Purity ≥98% by HPLC |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide, methanesulfonic acid; Dabrafenib Mesylate |
|---|
| Gene, Accession, CAS # | CAS: 1195768-06-9 |
|---|
| Catalog # | 2800-5 |
|---|
| Price | |
|---|
| Order / More Info | GSK-2118436 mesylate from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|